ANA Screen, IFA, with Reflex to Titer and Pattern
The ANA Screen, IFA, with Reflex to Titer and Pattern is often one of the first tests ordered when an autoimmune disorder is suspected. This blood test detects antinuclear antibodies (ANA) in your blood, which are proteins that mistakenly attack your body's healthy cells, specifically targeting the cell's nucleus. Doctors use the results of this immunofluorescence assay (IFA) to investigate concerning symptoms like persistent joint pain, fatigue, or swelling, and to guide the diagnostic evaluation for connective tissue diseases. It is a critical tool for helping to diagnose conditions such as systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome. A positive result doesn't automatically mean disease, but it provides essential information for your healthcare provider in determining the cause of your symptoms.
The long order name matches what people type when they screenshot a requisition: ANA by IFA with reflex to titer and pattern. IFA means human tissue or HEp-2 cells under a microscope, not an anonymous black-box assay. The screen is binary at first pass; reflex kicks in to dilute serum until fluorescence fades, producing a titre, and the technologist records a pattern. Positive does not equal lupus—healthy donors, other autoimmune diseases, chronic infections, and even some medications light this up. Negative ANA makes classic SLE less likely but does not erase rheumatology when the clinic picture screams. The mission is triage: decide whether nuclear-targeted autoimmunity belongs on the differential and how hard to chase it.
Self-Pay Price Comparison
| Provider | Price | vs. Highest | Order |
|---|---|---|---|
Quest QuestHealth self-pay | $89.60 | Highest | Order · Quest |
LabCorp Labcorp OnDemand | Not Available | N/A | Check Provider Site · LabCorp |
GoodLabs Discount lab network | $6.00Best value | Best price | Order · GoodLabs |
What This Test Measures
Positive screens unlock two extra lines clinicians actually argue about: how far your serum still stains at dilution, and which nuclear architecture lights up.
Immunofluorescence screen on fixed substrate looking for antibodies that bind nuclear antigens; a positive screen means fluorescence crossed the lab’s cutoff, a negative screen pushes many systemic lupus evaluations toward other diagnoses or repeat testing later.
Serial dilution reported as 1:40, 1:80, 1:160, and so on; higher titers generally mean more antibody still visible at depth, though titre alone never equals disease severity and low-positive titers show up in healthy people.
Describes how fluorescence lights up—homogeneous, speckled, nucleolar, centromere, and others—giving the lab a hint which antigens dominate; pattern steers follow-up extractable nuclear antigen testing but does not lock a single diagnosis.
How to Read Your Results
IFA reflex adds titre and pattern; here is how those three lines get read without turning fluorescence into a disease name.
| Marker | Normal Range | If Flagged | What It Might Mean |
|---|---|---|---|
| ANA screen (positive at low titre) | Many labs start reporting at 1:40 or 1:80; weak positives appear in healthy individuals and after certain drugs (MedlinePlus lab test, ANA (Antinuclear Antibody) Test). | abnormal | A low-titre positive is a yellow flag, not a brand. Rheumatology reads symptoms, joint exam, complements, urinalysis, and sometimes repeat titre on a new draw. Treatment does not follow the fluorescence alone. |
| ANA titre (rising) | Titres double in logarithmic steps; compare only within the same method and laboratory (MedlinePlus Medical Encyclopedia, Antinuclear antibody panel). | high | A climbing titre during symptomatic flares adds weight to an autoimmune hypothesis. Stable high titre with quiet exam may mean nothing new. The slope matters more than bragging rights about the number. |
| ANA pattern (speckled vs homogeneous vs nucleolar) | Patterns describe staining morphology, not automatic diagnoses; associations are probabilistic (MedlinePlus Medical Encyclopedia, Antinuclear antibody panel). | abnormal | Speckled often triggers ENA differentiation; homogeneous leans toward DNA-associated autoimmunity in teaching memory; nucleolar raises scleroderma spectrum questions. None of those shortcuts replace specific antibody tests. |
| ANA screen (negative) | Negative IFA makes untreated systemic lupus unlikely but not impossible in small subsets followed in specialty clinics (MedlinePlus lab test, ANA (Antinuclear Antibody) Test). | low | Seronegative lupus is rare enough that negatives redirect workup toward infection, malignancy, or alternative autoimmune markers. If the clinic picture still fits, rheumatology orders deeper assays rather than repeating ANA endlessly. |
When to Order
Photosensitive rash with joint pain and oral ulcers
That triad pushes toward systemic lupus and related connective-tissue disease. ANA is the wide net ordered early while urinalysis, complements, and specific antibodies fill in detail.
Dry eyes, dry mouth, and positive Ro/La history in the family
Sjögren spectrum disease often starts with sicca symptoms. ANA positivity is common; titre and pattern guide whether extractable nuclear antigen panels earn the next tube of blood.
Raynaud’s, swollen fingers, and skin thickening
Scleroderma-pattern autoimmunity frequently carries nuclear staining. ANA is not decorative here—it steers scleroderma-specific antibody testing that changes surveillance and referral speed.
Chronic hepatitis-flare pattern with transaminitis
Autoimmune hepatitis sits on the differential when liver enzymes misbehave without alcohol or viral story. ANA plus liver-focused antibodies and imaging stack together; this test is one layer, not the verdict.
Fatigue and arthritis with prior weak-positive ANA
Repeat ANA IFA tracks whether titre is climbing, stable, or clearing as symptoms evolve. Serial testing beats treating a single snapshot like a tattoo.
Prep & Logistics
- Fasting
- Typically no fasting
- Sample
- Blood draw from a standard arm vein
- Results
- Usually 2-4 business days when reflex staining is required; simple negatives can post faster.
- Referral
- Often self-order (check local rules)
- Markers
- IFA screen with reflex ANA titer and pattern on positive screens. Some medications and age can yield weakly positive low-titre results; tell the ordering clinician about drugs and symptoms.
Tests That Pair With This One
Inflammatory arthritis workups still pair RF with ANA early; discordant results narrow the field toward RA overlap versus lupus.
Systemic inflammation scoring helps decide how urgent rheumatology referral feels while specific antibodies are pending.
Acute-phase read that moves faster than ANA titre when infection and flare share the same week.
Cytopenias and lymphopenia belong in lupus activity scoring; the CBC is cheap context next to a positive ANA.
Liver enzyme and renal lines matter when autoimmune hepatitis or lupus nephritis sits on the differential.
FAQ
What does “ANA by IFA reflex to titer and pattern” actually run in the lab?
Technicians stain your serum on substrate cells and look for nuclear fluorescence. If the screen is negative, reporting stops. If positive, they dilute serum in steps to produce a titre and record the staining architecture as the pattern. That reflex is why the bill and turnaround can jump after the first pass.
Is an ANA IFA panel different from the ANA my friend had?
Method matters. IFA is still the classic screen rheumatologists trust for broad nuclear antibodies. Some labs add immunoassay ANA screens; results do not interchange line for line. Compare apples to apples when you trend titre over years.
My titre is 1:80 and speckled. Do I have lupus?
That combination is common in people without lupus and in several autoimmune diagnoses. titre and pattern steer what to test next—anti-dsDNA, complements, urinalysis—not what label to tattoo. Symptoms and exam decide, not the fluorescence photograph.
Can medicines make ANA positive?
Yes. Drug-induced lupus and simple ANA positivity show up with certain blood pressure meds, anti-arrhythmics, and biologics among others. Bring a complete medication list; sometimes the fix is stopping an offender, sometimes it is watching titre while symptoms settle.
Why not skip straight to expensive antibody subsets?
ANA IFA is the wide net; ENA-specific tests are precision tools after the net catches something. Ordering every antibody on day one wastes money and still misses diagnoses when the clinical story is wrong. Rheumatology sequences tests based on probability.
Sources
Quest and GoodLabs price lines need a live confirmation pass; IFA interpretation references pulled from MedlinePlus. Not generated by AI.
- GoodLabs - ANA Screen, IFA, with Reflex to Titer and Pattern (pricing context)(verified 2026-03-23)
- Quest - consumer lab shop (pricing context)(verified 2026-03-23)
- MedlinePlus - ANA (Antinuclear Antibody) Test overview
- MedlinePlus Medical Encyclopedia - Antinuclear antibody panel (titer and pattern context)
- Clinical context: LabRecon editorial team. Not medical advice. For informational use only.
IFA-based ANA screen with reflex to titer and pattern. Primary screen for systemic autoimmune diseases including SLE, Sjögren's, and mixed connective tissue disease.